
Henry Schein (HSIC) Stock Forecast & Price Target
Henry Schein (HSIC) Analyst Ratings
Bulls say
Henry Schein is expected to continue performing well due to its strong market demand, improved margins, and focus on growth. With new leadership and a resilient dental market, the company is well-positioned for international growth. Although there are concerns about potential changes in the economy and healthcare policies, the company’s positive outlook is further supported by its strong financials and successful transformations. Omnicell, a competing healthcare company, has also shown positive growth but faces integration challenges with recent acquisitions, making Henry Schein a more appealing investment option.
Bears say
Henry Schein is well-positioned in the dental market and global segments, however, there are concerns about its slow growth in the US due to a security breach and potential impacts from tariffs. Profitability is expected to improve with its value creation initiatives and partnerships, but there may be challenges in reaching previous levels of growth in the US market. Overall, while the company may face some short-term challenges, it is still a strong player in the healthcare industry and has potential for long-term growth.
This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.
Henry Schein (HSIC) Analyst Forecast & Price Prediction
Start investing in Henry Schein (HSIC)
Order type
Buy in
Order amount
Est. shares
0 shares